Plasma concentration of micafungin in patients with hematologic malignancies

Journal of Infection and Chemotherapy

Volumn 13, Issue 1, 2007, Pages 39-45

  Nakagawa, Yasunori ^a,c   Ichii, Yoko ^a   Saeki, Yasuhiro ^a   Kodaka, Masanobu ^a   Suzuki, Kenshi ^a   Kishino, Satoshi ^b  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

Febrile neutropenia; Fungal infection; Micafungin; Pharmacokinetics; Plasma concentration

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; FEMALE; HEMATOLOGIC MALIGNANCY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFECTION; INFUSION; KIDNEY DISEASE; KIDNEY FUNCTION TEST; LIVER DISEASE; LIVER FUNCTION TEST; MALE;

EID: 33847616637     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-006-0496-1     Document Type: Article

References (14)

1. S Kohno H Yamaguchi 2002 Overview of micafungin (MCFG) (in Japanese) Jpn J Chemother 50 S-1 1 7
2. Ikeda F, Otomo K, Nakai T, Morishita Y, Maki K, Tawara S, et al. In vitro activity of a new lipopeptide antifungal agent, micafungin against a variety of clinically important fungi (in Japanese). 2002;50(S-1):8-19
3. JH van Burik V Ratanatharathorn DE Stepan CB Miller JH Lipton DH Vesole 2004 Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation Clin Infect Dis 39 1407 16
4. T Ishikawa T Takata T Tomoyose M Masuda S Nakachi S Koga 2006 The efficacy of micafungin as an empiric therapy for febrile neutropenic patients refractory to antibacterial agents (in Japanese) Jpn J Chemother 54 125 8
5. M Yanada H Kiyoi M Murata M Suzuki M Iwai T Yokozawa 2006 Micafungin, a novel antifungal agent, as empirical therapy in acute leukemia patients with febrile neutropenia Intern Med 45 259 64
6. S Kohno T Masaoka H Yamaguchi T Mori A Urabe A Ito 2004 A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan Scand J Infect Dis 36 372 9
7. L Ostrosky-Zeichner D Kontoyiannis J Raffalli KM Mullane J Vazquez EJ Anaissie 2005 International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia Eur J Clin Microbiol Infect Dis 24 654 61
8. M Ruhnke E Kuse P Chetchotisakd CA da Cunha H Diekmann-Berndt 2005 Comparison of micafungin and liposomal amphotericin B for invasive candidiasis. Program, 228 (Abstract no. M-722c) Forty-fifth Interscience Conference on Antimicrobial Agents and Chemotherapy Washington DC December 16-19
9. Yamato Y, Kaneko H, Tanimoto K, Katashima M, Ishibashi K, Kawamura A, et al. Simultaneous determination of antifungal drug, micafungin, and its two active metabolites in human plasma using high-performance liquid chromatography with fluorescence detection (in Japanese). 2002;50(S-1):68-73
10. Azuma J, Nakahara K, Kagayama A, Kajiho T, Kawamura A, Suematsu H, et al. Phase I study of micafungin (in Japanese). 2002;50(S-1):104-47
11. Azuma J, Nakahara K, Kagayama A, Okuma T, Kawamura A, Mukai T. Pharmacokinetic study of micafungin (in Japanese). 2002;50(S-1):155-84
12. Azuma J, Nakahara K, Kagayama A, Fujiwara S, Kawamura A, Mukai T. Pharmacokinetic study of micafungin in elderly subjects (in Japanese). 2002;50(S-1):148-54
13. S Shimoeda S Ohta H Kobayashi H Saitou A Kubota S Yamato 2005 Analysis of the blood level of micafungin involving patients with hematological diseases: new findings regarding combination therapy with tacrolimus Biol Pharm Bull 28 477 80
14. D Andes Marchillo J Lowther A Bryskier T Stamstad R Conklin 2003 In vivo pharmacodynamics of HMR3270, a glucan synthase inhibitor, in a murine candidiasis model Antimicrob Agents Chemother 47 1187 92